Streetbeat News

Regulatory

INDV

Indivior's SUBLOCADE has received FDA priority review for a potential label expansion, with a PDUFA date set for February 7, 2025. The expansion could include rapid induction and alternative injection sites.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 3:31 pm

GTE

Gran Tierra Energy's acquisition of i3 Energy has been approved by i3 Energy shareholders, marking a significant step towards the completion of the deal. The acquisition is expected to be finalized by October 31, 2024, pending regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 3:23 pm

GILD

Gilead Sciences presented data from the PURPOSE 2 trial at the HIVR4P conference, showing that its drug Lenacapavir reduced HIV infections by 96% among cisgender men and gender-diverse people. Gilead plans to file for regulatory approval for Lenacapavir as PrEP by the end of 2024 and aims to expand access in high-incidence, resource-limited countries.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 3:04 pm

FXI

Goldman Sachs predicts China's stock market rally could extend another 15% to 20% due to policy support, low valuations, reduced investment risk, and potential earnings growth. Despite challenges, the market has seen significant gains driven by Beijing's stimulus measures.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 3:01 pm

GIS

PEP

Sen. Elizabeth Warren and Rep. Madeleine Dean have accused major food and beverage companies, including General Mills, Coca-Cola, and PepsiCo, of engaging in 'shrinkflation'—reducing product sizes while maintaining or increasing prices. They also criticized these companies for benefiting from tax cuts and paying lower tax rates than many individuals. The lawmakers have demanded transparency on pricing and tax practices from these corporations.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 2:48 pm

TRVN

Trevena Inc (NASDAQ:TRVN) shares plummeted by 43.3% after the company announced it received a Nasdaq delisting notification due to failure to meet minimum stockholder equity requirements. The stock will be delisted on October 8 and is expected to trade on the Pink Open Market.

Portfolio Pulse from Henry Khederian

October 07, 2024 | 2:38 pm

CETY

Clean Energy Technologies, Inc. (CETY) announced that its affiliate, Vermont Renewable Gas, LLC, has secured a $1M USDA REAP grant to advance its biomass and waste-to-energy technologies. This funding will support the development of a 2.2-megawatt renewable energy facility in Lyndon, Vermont.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 2:34 pm

EIS

ISRA

SPY

USO

Russian President Vladimir Putin is scheduled to meet with Iran's President on October 11, as reported by Reuters citing IFAX. This meeting could have geopolitical implications, potentially affecting global markets and specific sectors.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 2:32 pm

BIIB

RHHBY

SRRK

Scholar Rock's apitegromab shows promising results in a Phase 3 trial for spinal muscular atrophy, leading to a significant stock price increase. The company plans to submit FDA and European marketing applications in 2025.

Portfolio Pulse from Vandana Singh

October 07, 2024 | 2:23 pm

LLY

NVO

REGN

Regeneron's Chief Scientific Officer, George Yancopoulos, has raised concerns about the health risks of GLP-1 weight-loss drugs like Ozempic, citing rapid muscle loss as a significant issue. Regeneron is developing muscle-preserving treatments to address this, including a Phase 2 trial for trevogrumab. Eli Lilly has also entered the obesity drug market with its acquisition of Versanis Bio.

Portfolio Pulse from Vandana Singh

October 07, 2024 | 1:57 pm